N. Triller (Golnik, Slovenia), I. Rousalova (Prague, Czech Republic), N. Schoenfeld (Berlin, Germany), D. Jovanovic (Beograd, Republic of Serbia)
EBUS-TBNA for nodal restaging and relapse in lung cancer
M. Enderle, P. Hoffknecht, G. May, H. Schubert, S. Rüther, S. Fischer, P. Zardo, N. Dickgreber (Rheine, Ibbenbüren, Magdeburg, Germany)
|  |
Predictive CT-parameters for detection with and diagnostic accuracy of EBUS-guided biopsy of suspected lung lesions
C. Guvenc, W. De wever, F. Zanca, A. Carbonez, J. Yserbyt, D. Testelmans, C. Dooms (Leuven, Belgium)
| |
Diagnostic yield of flexible bronchoscopy: A retrospective study over six months
A. Werpachowska, T. Kakoudaki, S. Faruqi (Hull, United Kingdom)
| |
The provision of EBUS-TBNA services across a UK lung cancer network; a report from the Greater Manchester and Cheshire Lung Cancer Network EBUS Sub-Group
M. Evison, P. Crosbie, J. Martin, R. Shah, H. Doran, J. Hoyle, S. Bailey, D. Rana, R. Sundar, R. Booton (Manchester, Wigan, United Kingdom)
| |
Should bronchoscopy be performed in all patients with haemoptysis and a normal CT chest?
M. Ahmed, M. B. Ganaie, M. Haris, I. Hussain (Stoke-on-Trent, United Kingdom)
|  |
The efficacy of convex probe endobronchial ultrasound for sampling of parenchymal lung lesions
N. Akasheh, J. Lyons, A. Rani, F. O'Connell (Dublin, Ireland)
| |
The utility of simulation map by workstation for diagnostic bronchoscopy
Y. Matsumoto, T. Izumo, T. Tsuchida, S. Sasada (Tokyo, Japan)
| |
Mediastinal lymph nodes (MLN) vascular pattern utilitiy to predict progression in lung cancer
A. Donate Salcedo, A. V. Quintero Salvago, M. Fontillón, L. Gómez Izquierdo, B. Romero Romero, J. Martín Juan (Sevilla, Spain)
| |
Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study
M. Szturmowicz, P. Rudzinski, R. Langfort, I. Bestry, A. Kacprzak, B. Broniarek-Samson, T. Orlowski (Warsaw, Poland)
| |
Preliminary results of first year of application of cardiopulmonary exercise test (CPET) in resection lung surgery in Navarra (Spain)
S. Herrero, V. López, A. Urrizburu, M. J. Martínez, J. J. Lorza, J. J. Guelbenzu, X. López, P. Cebollero (Pamplona, Spain)
| |
Impact of acute admissions and readmissions in patients with lung cancer for patients and the hospital
C. Hayton, V. Sibanda, I. Aziz, R. Sundar (Wigan, United Kingdom)
| |
Prospective assessment of incidental respiratory symptoms in COPD (PAIRS-COPD), feasibility study
A. Zarmouh, D. Bowen, M. Boon, T. Rogers (Doncaster, Conisbrough, United Kingdom)
| |
The research on early detection of lung cancer with exhaled volatile organic compounds
Y. Hu, K. Ying (Hangzhou, China)
| |
Bronchiolo-alveolar carcinoma- sometimes a difficult diagnosis
M. Preda, I. Belaconi, C. Toma, T. Constantinescu, A. Croitoru, S. Dumitrache-Rujinski, M. Bogdan (Bucharest, Romania)
| |
Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer
S. Michaelides, A. Emmanouelidou, G. Bablekos, G. Ionas, H. Ellina, N. Maouni, I. Platanos (Athens, Greece)
| |
The utility of fluorodeoxyglucose positron emission tomographyin the evaluation of carcinoid tumors presenting as pulmonary nodules. Experience in our hospital
V. López, S. Herrero, A. Iridoy, J. Cascante, A. Panizo, M. Garcia, J. Hueto (Pamplona, Spain)
| |
False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer
K. Athanassiadi, A. Makrygianni, E. Balis, N. Alevizopoulos, M. Vaslamatzis, C. Vourlakou (Athens, Greece)
| |
Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption
C. Clément-Duchêne, I. Lemonnier, F. Guillemin, J. M. Vignaud, G. Gauchotte, S. Lacomme, G. Grosdidier, J. Siat, Y. Martinet (Vandoeuvre-Lès-Nancy, Nancy, France)
| |
Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?
F. Yildirim, M. Türk, U. O. Akdemir, I. Tastepe, A. S. Yurdakul (Ankara, Turkey)
| |
The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment
J. Baker, A. Banerjee (Southampton, United Kingdom)
| |